Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-28

FDA Approved: ALEVE PM — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for ALEVE PM (diphenhydramine hydrochloride and naproxen sodium) to support its continued marketing as the combination p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALEVE PM (DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM)

Snippet

SUPPL AP for ALEVE PM (DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM)